NPPB and myocardial ischemia: For this purpose we investigated the beneficial effects of the AT-1 receptor antagonist irbesartan on B-type natriuretic peptide (BNP), a plasmatic marker increased in patients with myocardial ischemia, on TLRs pathway and on oxidative balance.